Laurus Synthesis, is a leading small molecule Contract Development & Manufacturing Organization (CDMO) of Laurus Labs with operations in India and the United States., offering end-to-end pharmaceutical development and manufacturing solutions for small molecule Active Pharmaceutical Ingredients (APIs) and finished dosage forms.
Laurus offers integrated drug substance and drug product solutions, from early clinical Phase I to commercial scale production, supported by collaborative teams throughout the program with industry-leading expertise. Our development and manufacturing sites work together to offer highly integrated operations to mitigate your supply chain risks. Our drug substance and drug product manufacturing sites have been audited by global regulatory agencies including the USFDA.
Our integrated offering brings together Drug substance development and manufacturing, Formulation Development and manufacturing, Analytical development, Regulatory Affairs, Packaging Development and Developmental QA functions.
Our state-of-the-art oral finished dosage facility in Visakhapatnam, India conforms to international regulatory standards. This facility has a commercial capacity of 10 billion units.